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Generation	 of	 endogenous	 BMP	 transcriptional	 reporter	 cells	 through	 CRISPR/Cas9	
genome	editing	
	
Luke	Hutchinson,	Polyxeni	Bozatzi,	Thomas	Macartney	and	Gopal	P.	Sapkota	
MRC	Protein	Phosphorylation	and	Ubiquitylation	Unit,	University	of	Dundee,	Sir	James	Black	
Centre,	Dow	Street,	Dundee,	Scotland,	UK.	
	
Abstract	
Transcriptional	reporter	systems	allow	researchers	to	investigate	the	function	and	regulation	
of	transcription	factors.	Conventional	systems	employ	artificial	cDNA	overexpression	vectors	
containing	either	a	promoter	fragment	or	specific	nucleotide	sequence	repeats	upstream	of	
firefly	luciferase	or	fluorescent	reporters,	such	as	green	fluorescence	protein	(GFP)	cDNA	(1).	
These	systems	suffer	mainly	from	the	lack	of	chromatin	context.	Here,	we	describe	the	rapid	
generation	of	endogenous	transcriptional	reporter	cells	for	the	Bone	Morphogenetic	Protein	
(BMP)	 pathway	 using	 CRISPR/Cas9	 genome	 editing.	 In	 principle,	 our	methodology	 can	 be	
applied	 to	 any	 cell	 line.	 The	 endogenous	 reporters	 will	 provide	 a	 robust	 system	 for	 the	
investigation	 of	 BMP	 transcriptional	 activity	 in	 the	 context	 of	 native	 chromatin	 landscape	
and	facilitate	chemical	and	genetic	screens.	
	
Introduction	
Bone	Morphogenetic	Proteins	(BMPs)	are	members	of	the	Transforming	Growth	Factor	Beta	
(TGFβ)	 superfamily	 of	 cytokines,	 with	 crucial	 roles	 in	 embryogenesis	 and	 adult	 tissue	
homeostasis.	 Aberrant	 BMP	 signaling	 is	 thus	 associated	 with	 numerous	 developmental	
defects	 and	 human	 pathologies	 (2).	 BMPs	 signal	 via	 binding	 to	 and	 activation	 of	 cognate	
type	 I	 and	 type	 II	 BMP	 receptor	 serine/threonine	 kinases.	 The	 activated	 type	 I	 BMP	
receptors	subsequently	phosphorylate	the	intracellular	SMAD	transcription	factors	1,	5	and	
8	 at	 a	 C-terminal	 Ser-X-Ser	 motif,	 thereby	 inducing	 their	 interaction	 with	 the	 common	
mediator	 SMAD4.	 The	 SMAD1/5/8-SMAD4	 complex	 is	 then	 able	 to	 translocate	 into	 the	
nucleus,	 where	 it	 associates	 with	 various	 transcriptional	 co-factors	 to	 regulate	 gene	
expression	 (3).	 Inhibitor	 of	 differentiation	1	 (ID-1),	 a	 dominant	 negative	 regulator	 of	 basic	
helix-loop-helix	 (bHLH)	 transcription	 factors,	 is	 a	 direct	 gene	 target	 of	 BMP	 signaling	 (4).	
Therefore,	 ID-1	 mRNA	 and	 protein	 expression	 is	 frequently	 employed	 as	 a	 downstream	
readout	of	the	BMP	signaling	pathway.	
	 We	have	previously	reported	the	generation	of	endogenous	transcriptional	reporter	
cells	for	the	TGFβ	pathway	using	CRISPR/Cas9	genome	editing	(5).	This	system	involved	the	
insertion	of	a	transcriptional	reporter	cassette	downstream	of	the	endogenous	promoter	for	
the	TGFβ	target	gene	plasminogen	activator	inhibitor	1	(PAI-1).	In	the	following	protocol,	we	
describe	the	generation	of	an	endogenous	BMP	transcriptional	reporter	cell	line,	in	which	a	
reporter	cassette	containing	 firefly	 luciferase	 and	GFP	 gene,	has	been	 inserted	adjacent	 to	
the	endogenous	 ID-1	 promoter	 sequence.	The	generation	of	 the	 cell	 line	 thus	enables	 the	
study	 of	 endogenous	 BMP	 transcriptional	 activity	 as	 well	 as	 chemical	 and	 genetic	 high-
throughput	screens.	
	
	
	
2.	Materials	
	
2.1	Mammalian	cell	culture	and	cell	transfection	reagents	
	
1. Dulbecco’s	Phosphate	Buffered	Saline	(DPBS)	1x		
2. 0.05%	Trypsin-EDTA	
3. Dulbecco’s	Modified	Eagle	Medium	(DMEM),	4.5	g	L-1	D-Glucose	
4. Fetal	Bovine	Serum	(FBS)	
5. Penicillin-Streptomycin	(10,000	Units	mL-1)	
6. L-Glutamine	(200	mM)	
7. Opti-MEM	(Reduced	Serum	Medium)	
8. Polyethyleneimine	(PEI)	MAX	(MW	25000)	
	
2.2	Cytokines	and	inhibitors	
	
1. Recombinant	Human	BMP-2	Protein	
2. SB-505124	(ALK4/5/7	inhibitor)	
3. LDN193189	(ALK2/3	inhibitor)	
4. DMSO	
	
2.3	Luciferase	assay	
	
1. 2x	 Luciferase	 Assay	 Buffer:	 50	mM	Tris/phosphate	 (pH	 7.8),	 16	mM	MgCl2,	 2	mM	
DTT	(Dithiothreitol),	1	mM	ATP,	30%	(v/v)	glycerol,	1%	(w/v)	bovine	serum	albumin	
(BSA),	250	µM	D-Luciferin	and	8	µM	sodium	pyrophosphate.	
2. Luciferase	Cell	Culture	Lysis	5X	Reagent	(CCLR)	
3. Cell	Culture	Microplate	(96-well),	Flat-Bottom,	White,	Sterile	
4. Plateseal,	Permanent	Seal	for	Microplates	
5. EnVision	Multilabel	Plate	Reader	(2104-0010A,	PerkinElmer)	
6. Coomassie	(Bradford)	Protein	Assay	Kit	
	
3.	Methods	
	
3.1	Design	of	guide	RNA	(gRNA)	
A	 dual	 guide	 RNA	 (gRNA)	 approach	 was	 undertaken	 with	 sense	 and	 antisense	 gRNAs	
designed	 to	 target	 a	 region	 (corresponding	 to	 nucleotides	 41-84)	 within	 the	 N-terminal	
coding	region	of	the	ID-1	gene.	
	
• Sense	 gRNA	 (5’-CGGCAAGACAGCGAGCGGTGCGG-3’)	 cloned	 into	 pBABE-Puro	 U6	
vector	containing	puromycin	resistance	sequence	
• Antisense	gRNA	 (5’-CGGCCTTCAGCGCGCAGCTGGGG-3’)	 cloned	 into	a	pX335	vector	
containing	the	Cas9-D10A	nuclease	sequence	
	
	
	
3.2	Construction	of	donor	vector	containing	the	polycistronic	reporter	cassette	
A	donor	vector	containing	the	following	components	was	designed	to	be	 inserted	in-frame	
at	the	ATG	start	codon	of	ID-1.	
	
• Complementary	 DNA	 (cDNA)	 sequences	 encoding	 for	 firefly	 luciferase	 and	 green	
fluorescent	protein	(GFP)	
	
• Two	 regions	 (approximately	 500	 nucleotides)	 homologous	 to	 the	 ID-1	 gene	 locus	
around	 the	 start	 codon,	 located	 upstream	 and	 downstream	 of	 the	 cassette,	 to	
facilitate	homologous	recombination	
	
• Silent	mutations	were	 included	 in	 the	 downstream	homologous	 region	 to	 prevent	
cleavage	by	the	gRNA-directed	Cas9	nuclease	
	
• An	 internal	 ribosome	 entry	 site	 (IRES)	 element	 was	 incorporated	 immediately	
downstream	 of	 the	 luciferase	 gene	 to	 enable	 separate	 expression	 of	 GFP	 and	
luciferase	enzyme	from	the	same	donor	vector	
	
• A	sequence	encoding	the	2A	self-cleaving	peptide,	 located	downstream	of	the	GFP	
gene,	ensures	cleavage	of	the	GFP	protein	from	the	endogenous	ID-1	protein	
	
3.3	Transfection	of	gRNA	and	donor	vector	
Immortalized	human	 keratinocyte	HaCaT	 cells	were	 cultured	 in	Dulbecco’s	Modified	 Eagle	
Medium	(DMEM)	supplemented	with	10%	(v/v)	fetal	bovine	serum	(FBS),	2	mM	L-glutamine,	
100	 units	mL-1	 penicillin	 and	 100	 µg	mL-1	 streptomycin	 (subsequently	 referred	 to	 as	 D10F	
medium).	(Note:	Conditioned	D10F	medium	was	collected	from	routine	HaCaT	cultures	and	
filtered	for	single	cell	isolation	during	FACS	sorting).	Cells	were	cultured	in	10-cm	cell	culture	
plates	in	9	mL	D10F	medium	and	transfected	at	approximately	60%	confluency.	
	
1. Prepare	transfection	solution	by	adding	1	µg	of	sense	gRNA,	1	µg	anti-sense	gRNA,	3	
µg	 cDNA	 donor	 vector	 and	 20	 µL	 PEI	 (1	 µg	 mL-1	 stock	 concentration)	 to	 1	 mL	 of	
sterile	Opti-MEM	(Reduced	Serum	Media)	in	a	15-mL	conical	centrifuge	tube.	Vortex	
for	20	s	and	incubate	at	room	temperature	for	15	min.		
	
2. Add	transfection	solution	drop-wise	to	the	cells,	cultured	in	9	mL	of	D10F	medium.	
	
3. 24-hours	 post-transfection,	 exchange	 medium	 for	 10	 mL	 fresh	 D10F	 medium	
supplemented	with	2	µg	mL-1	puromycin	(Note:	include	an	untransfected	control	cell	
plate	to	assess	effectiveness	of	antibiotic	selection	treatment).	
	
4. 48-hours	post-transfection,	exchange	medium	for	D10F	medium	supplemented	with	
2	µg	mL-1	puromycin.	
	
5. 72-hours	post-transfection,	exchange	medium	for	D10F	without	additional	antibiotic	
and	 allow	 the	 cells	 to	 recover	 for	 24	 hours	 (Optional:	 in	 order	 to	 increase	 the	
efficiency	 of	 homologous	 recombination,	 perform	 a	 repeat	 transfection	 and	
antibiotic	selection	on	the	same	cells	following	an	identical	procedure).	
	
6. Allow	 cells	 to	 grow	 until	 approximately	 90%	 confluent	 and	 prepare	 them	 for	
fluorescence-activated	cell	sorting	(FACS).	
	
3.4	Fluorescence-activated	cell	sorting	(FACS)	
	
1. Aspirate	medium	and	wash	cells	twice	with	1x	Dulbecco’s	Phosphate	Buffered	Saline	
(DPBS).	
	
2. Add	trypsin	(2	mL	per	10	cm	plate)	and	incubate	at	37°C	for	5-10	minutes	until	the	
cells	detach.	Re-suspend	cells	in	10	mL	D10F	medium.	
	
3. Transfer	cell	suspension	into	a	15	mL	conical	centrifuge	tube	and	centrifuge	at	500	
r.p.m.	for	3	minutes.	
	
4. Aspirate	the	supernatant	and	resuspend	the	cell	pellet	in	DMEM	supplemented	with	
1%	(v/v)	FBS	at	a	density	of	2.0-5.0	x106	cells	mL-1.	
	
5. Single	 cells	 are	 identified	 on	 the	 basis	 of	 FSC-A,	 FSC-W	 and	 SSC-A	 and	 GFP	
fluorescence	measured	with	488	nm	excitation	and	emission	detected	at	530	±	30	
nm.	
	
6. Collect	 individual	GFP	expressing	cells	 into	 individual	wells	of	a	96-well	cell	culture	
plate	containing	conditioned	D10F	medium	supplemented	with	20%	(v/v)	FBS	(Note:	
centrifuge	the	96-well	plate	at	300	x	g	for	approximately	30	seconds	to	ensure	single	
cells	are	at	the	bottom	of	the	wells).	
	
7. Cells	were	 allowed	 to	 proliferate	 and	 transferred	 into	 progressively	 larger	 surface	
area	 cell	 culture	 plates	 until	 sufficient	 numbers	 are	 obtained	 for	 subsequent	
analysis.	
	
3.5	BMP	signaling	analysis	on	reporter	cells	
Single	cell	clones	which	were	positive	for	GFP	expression	and	exhibited	enhanced	luciferase	
activity	 compared	 to	 control	 cells	were	 subsequently	 analysed	 for	 responsiveness	 to	 BMP	
stimulation.	
	
1. Seed	 1.0	 x	 105	 cells	 per	 well	 in	 a	 6-well	 cell	 culture	 plate	 and	 culture	 until	
approximately	60%	confluent.	
	
2. Replace	medium	with	serum-free	DMEM	for	approximately	16	hours	(Note:	serum-
deprivation	 minimizes	 basal	 autocrine	 growth	 factor/cytokine	 signalling,	 thereby	
enabling	 the	 investigation	 of	 a	 single	 signalling	 pathway;	 in	 this	 instance	 the	 BMP	
signalling	pathway).	
	
3. Prepare	the	required	small	molecule	inhibitors	in	serum-free	DMEM,	in	the	presence	
or	absence	of	6.25	ng	mL-1	BMP-2,	in	15	mL	conical	centrifuge	tubes.	
	
4. The	 BMP	 type	 I	 receptor	 (ALK2/3)	 inhibitor	 LDN-193189	 can	 used	 at	 100	 nM	
concentration	as	a	positive	control	 for	BMP	pathway	 inhibition,	whereas	 the	TGFβ	
type	I	receptor	(ALK4/5/7)	inhibitor	SB-505124	can	be	used	at	1	µM	concentration	as	
a	negative	control	for	BMP	pathway	inhibition.	
	
5. Aspirate	 serum-free	 DMEM	 and	 dispense	 2	 mL	 of	 each	 cytokine	 and/or	 inhibitor	
combination	 into	 the	 appropriate	 well.	 Incubate	 for	 6-8	 hours	 at	 37°C	 (Note:	 6-8	
hour	 incubation	with	 6.25	 ng	mL-1	 BMP-2	 is	 sufficient	 to	 enable	 the	 expression	 of	
endogenous	ID-1	transcriptional	reporter	cassette).	
	
3.6	Luciferase	Assay	
	
1. Prepare	1x	luciferase	lysis	buffer	by	adding	1	volume	of	5x	Cell	Culture	Lysis	Reagent	
to	 4	 volumes	 of	 ultrapure	 deionized	 H2O	 (Note:	 equilibrate	 1x	 CCLR	 to	 room	
temperature	prior	to	use).	
	
2. Aspirate	media	and	wash	cells	twice	with	1x	DPBS	to	remove	culture	medium	(Note:	
perform	at	room	temperature).	
	
3. Dispense	sufficient	volume	of	1x	CCLR	to	cover	the	cells	(approximately	300	µL	per	
well	 in	 a	 6-well	 cell	 culture	 plate)	 and	 incubate	 cells	 for	 5-10	 minutes	 at	 room	
temperature	with	gentle	agitation	in	a	shaker.	
	
4. Scrape	 the	 cells	 from	 the	 plate	 surface	 and	 transfer	 lysates	 into	 1.5	 mL	
microcentrifuge	tubes	on	ice.	
	
5. Vortex	 the	 cell	 lysates	 for	 10-15	 seconds	 and	 then	 centrifuge	 at	 12,000	 x	 g	 for	 2	
minutes	at	4°C.	Transfer	the	supernatant	into	new	1.5	mL	microcentrifuge	tubes	
	
6. Dispense	40	µL	of	clarified	cell	 lysate	per	well	of	a	96-well	microplate	 (in	 triplicate	
for	 each	 condition)	 and	 subsequently	 add	 an	 equal	 volume	of	 2x	 Luciferase	Assay	
Buffer	per	well.	
	
7. Seal	 the	 microplate	 with	 adherent	 sealing	 tape	 and	 place	 the	 microplate	 on	 a	
vibrating	platform	for	30-60	seconds.	Immediately	obtain	luminescence	values	using	
a	microplate	 reader.	 (Note:	 It	 is	very	 important	 to	minimise	 the	 time	between	the	
addition	 of	 the	 luciferase	 assay	 buffer	 and	 obtaining	 the	 luminescence	 values.	
Therefore,	ensure	all	equipment	and	reagents	are	prepared	prior	to	the	addition	of	
the	buffer).	An	example	of	BMP-dependent	luciferase	activity	using	the	endogenous	
BMP	reporter	cells	is	included	in	Figure	1.	
	
8. Use	residual	cell	 lysate	 to	determine	 the	protein	concentration	 for	each	sample	 to	
enable	normalisation	of	luminescence	values.	
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Figure	Legend:	
	
Figure	1:	Validation	of	the	BMP	transcriptional	reporter	HaCaT	cells:	GFP-positive	single	cell	
isolate	(clone	4)	was	expanded	and	tested	for	the	 insertion	of	the	reporter	cassette	at	the	
correct	 locus	 using	 BMP-induction	 and	 BMPR1	 (LDN-193189)	 and	 TGFBR1	 (SB-505124)	
inhibitors,	as	indicated.	
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